Purchase Order 36C26224P0024

Award Date 10/1/23
Potential Completion Date 9/30/24
Potential Value $185K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $456,032.74, was issued by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, on October 1, 2024. The contract is a firm-fixed-price delivery order under an Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA, with a performance period through September 30, 2025. Jubilant Radiopharma, a for-profit organization and self-certified small...
This federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, is a $478,318.97 firm fixed-price purchase order issued by the Department of Veterans Affairs (VA) for the provision of radiopharmaceutical products and services. The contract has an ultimate completion date of April 30, 2025 and is not set aside for any particular business type. Jubilant Radiopharma is a self-certified small disadvantaged business that specializes in supplying...
This federal contract award to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) is for the supply of nuclear medicine imaging radio-therapeutic isotopes to the Department of Veterans Affairs (VA). The $843,077.64 firm-fixed-price delivery order contract has a performance period extending through February 28, 2026. Jubilant Radiopharma, a for-profit small disadvantaged business, specializes in manufacturing, distributing, and supplying radiopharmaceuticals and...
This federal contract award, valued at $83,454.67, was issued by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The contract is for the delivery of radiopharmaceuticals, which are specialized nuclear medicine products used in diagnostic imaging and treatment procedures for veterans and military personnel. The contract is a delivery order under a larger Indefinite...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $93,446.62 firm fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. This contract is to provide radiopharmaceuticals supporting nuclear medicine services and procedures for veterans at VA medical facilities. Jubilant Radiopharma has held multiple indefinite delivery contracts and blanket purchase...
This federal contract award is for the procurement of RADIOPHARMACEUTICALS by the Department of Veterans Affairs (VA) through VA's Network Contracting Office 20. The contract was awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a small disadvantaged business. The firm-fixed-price contract has a ceiling value of $111,944.77 and a period of performance through June 30, 2024. Jubilant Radiopharma is a key supplier of radiopharmaceuticals and nuclear...
This is a federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business that specializes in manufacturing and supplying radiopharmaceuticals and nuclear medicine products. The contract, valued at $122,387.32, is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) for the provision of radiopharmaceuticals such as Ga-68 Dotatate, iodine I-123, technetium-99m, and other specialized medical...
The U.S. Department of Veterans Affairs (VA) awarded a $150,000.00 firm-fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA's Veterans Integrated Service Network (VISN) 10, which covers the supply of specialized...
This contract award is for the supply of nuclear medicine radiopharmaceuticals to the Department of Veterans Affairs (VA). The prime contractor is Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. This award has a ceiling value of $73,037 and is a firm-fixed-price delivery order contract. Jubilant Radiopharma provides a variety of essential medical isotopes and radiopharmaceuticals used in diagnostic imaging and cancer...
This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract, valued at $31,268.14, is for the supply of radiopharmaceuticals and nuclear medicine products to support diagnostic and treatment capabilities for veterans at VA medical facilities. Jubilant Radiopharma has been awarded multiple Indefinite Delivery...

This federal contract award, valued at $184,507.80, was issued by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract is for the delivery of radiopharmaceuticals, which are specialized medical isotopes and imaging agents used in nuclear medicine procedures to support diagnostic imaging and cancer treatment services for veterans.

Jubilant Radiopharma is a for-profit, self-certified small disadvantaged business that plays a critical role in providing essential medical isotopes and radiopharmaceuticals to federal healthcare agencies, primarily the VA. The contract has a firm fixed-price pricing structure and a performance period ending on September 30, 2024.

This award is part of Jubilant Radiopharma's broader contract portfolio with the VA, which includes several significant Indefinite Delivery Vehicles (IDVs) valued up to $39.8 million. These IDVs enable the VA to efficiently procure radiopharmaceuticals and related services across its nationwide network of medical facilities to support nuclear medicine procedures for veterans.

Generated 4/24/25, 10:01 AM